Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 11
Submit an article Journal homepage
66
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors

Athanasios Anagnostopoulos Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
,
Dimitra Gika Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
,
George Hamilos Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
,
Konstantinos Zervas Department of Hematology Theagenion Cancer Center Thessaloniki Greece
,
Athanasios Zomas Department of Hematology Genimata General Hospital Athens Greece
,
Anastasia Pouli Department of Hematology Agios Savvas Cancer Center Athens Greece
,
Markela Zorzou Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
,
Efstathios Kastritis Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
,
Nikolaos Anagnostopoulos Department of Hematology Genimata General Hospital Athens Greece
,
Anna Tassidou Department of Hematopathology Evangelismos General Hospital Athens Greece
,
Dimitra Anagnostou Department of Hematopathology Evangelismos General Hospital Athens Greece
&
Meletios-Athanasios Dimopoulos Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece
 show all
Pages 2275-2279 | Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christopher P. Venner, Joseph M. Connors, Heather J. Sutherland, John D. Shepherd, Linda Hamata, Yasser Abou Mourad, Michael J. Barnett, Raewyn Broady, Donna L. Forrest, Donna E. Hogge, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Janet Nitta, Maryse M. Power, Cynthia L. Toze, Clayton A. Smith & Kevin W. Song. (2011) Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months). Leukemia & Lymphoma 52:1, pages 34-41.
Read now
Miki Nakamura, Tomomi Gotoh, Yutaka Okuno, Hiro Tatetsu, Takashi Sonoki, Shima Uneda, Masataka Mori, Hiroaki Mitsuya & Hiroyuki Hata. (2006) Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & Lymphoma 47:3, pages 531-539.
Read now

Articles from other publishers (11)

Li Wei, Yuting Gao, Katharina Theresa Prochazka, Rongqiu Liu, Liang Wang, Boyang Liu, Yingzhi He, Luca Bertero, Alessia Pellerino, Paola Cassoni, Luca Tamagnone, Alexander J. Deutsch, Huien Zhan, Jing Lai, Seok Jin Kim & Hua You. (2023) A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study. Journal of Neuro-Oncology 163:2, pages 301-311.
Crossref
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios‐Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson & Joan Bladé. (2021) Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British Journal of Haematology 194:3, pages 496-507.
Crossref
Despina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2018) How We Manage Patients with Plasmacytomas. Current Hematologic Malignancy Reports 13:3, pages 227-235.
Crossref
Joan Bladé & Laura Rosiñol. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 585 593 .
Morie A. Gertz, Laura Rosinol & Joan Bladé. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms 157 175 .
Olivier Decaux, Alain Renault, Véronique Sébille, Philippe Moreau, Michel Attal, Laurent Voillat, Brigitte Pegourie, Mourad Tiab, Thierry Facon, Robert Zerbib, Bernard Grosbois & Eric Bellissant. (2012) Predictive Factors of Survival After Thalidomide Therapy in Advanced Multiple Myeloma: Long-Term Follow-Up of a Prospective Multicenter Nonrandomized Phase II Study in 120 Patients. Clinical Lymphoma Myeloma and Leukemia 12:6, pages 418-422.
Crossref
Joan BladéCarlos Fernández de LarreaLaura RosiñolMaría Teresa CibeiraRaquel JiménezRay Powles. (2011) Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach. Journal of Clinical Oncology 29:28, pages 3805-3812.
Crossref
Marcello RottaBarry E. StorerFiroozeh SahebiJudith A. ShizuruBenedetto BrunoThoralf LangeEdward D. AguraPeter A. McSweeneyMichael A. PulsipherParameswaran HariRichard T. Maziarz, Thomas R. Chauncey, Frederick R. AppelbaumMohamed L. SorrorWilliam BensingerBrenda M. SandmaierRainer F. StorbDavid G. Maloney. (2009) Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood 113:14, pages 3383-3391.
Crossref
Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Piero Galieni, Giuseppe Visani, Francesco Alesiani, Massimo Catarini, Marino Brunori, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Luciano Giuliodori, Marco Candela, Anna Mele, Monica Marconi & Pietro Leoni. (2008) Serum C-Reactive Protein at Diagnosis and Response to Therapy Is the Most Powerful Factor Predicting Outcome of Multiple Myeloma Treated with Thalidomide/Anthracycline—Based Therapy. Clinical Lymphoma and Myeloma 8:5, pages 294-299.
Crossref
Yutaka Hattori, Shin-ichiro Okamoto, Naoki Shimada, Tsunayuki Kakimoto, Kunihiko Morita, Yusuke Tanigawara & Yasuo Ikeda. (2008) Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile. Cancer Science 99:6, pages 1243-1250.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:4, pages 183-190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.